687 related articles for article (PubMed ID: 9529249)
1. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.
Zhang Y; Xiong Y; Yarbrough WG
Cell; 1998 Mar; 92(6):725-34. PubMed ID: 9529249
[TBL] [Abstract][Full Text] [Related]
2. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53.
Zhang Y; Xiong Y
Mol Cell; 1999 May; 3(5):579-91. PubMed ID: 10360174
[TBL] [Abstract][Full Text] [Related]
3. Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status.
Saadatmandi N; Tyler T; Huang Y; Haghighi A; Frost G; Borgstrom P; Gjerset RA
Cancer Gene Ther; 2002 Oct; 9(10):830-9. PubMed ID: 12224024
[TBL] [Abstract][Full Text] [Related]
4. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.
Stott FJ; Bates S; James MC; McConnell BB; Starborg M; Brookes S; Palmero I; Ryan K; Hara E; Vousden KH; Peters G
EMBO J; 1998 Sep; 17(17):5001-14. PubMed ID: 9724636
[TBL] [Abstract][Full Text] [Related]
5. ARF promotes accumulation of retinoblastoma protein through inhibition of MDM2.
Chang DL; Qiu W; Ying H; Zhang Y; Chen CY; Xiao ZX
Oncogene; 2007 Jul; 26(32):4627-34. PubMed ID: 17297463
[TBL] [Abstract][Full Text] [Related]
6. Human ARF binds E2F1 and inhibits its transcriptional activity.
Eymin B; Karayan L; Séité P; Brambilla C; Brambilla E; Larsen CJ; Gazzéri S
Oncogene; 2001 Mar; 20(9):1033-41. PubMed ID: 11314038
[TBL] [Abstract][Full Text] [Related]
7. Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways.
Zhao L; Samuels T; Winckler S; Korgaonkar C; Tompkins V; Horne MC; Quelle DE
Mol Cancer Res; 2003 Jan; 1(3):195-206. PubMed ID: 12556559
[TBL] [Abstract][Full Text] [Related]
8. P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2.
Tao W; Levine AJ
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6937-41. PubMed ID: 10359817
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
[TBL] [Abstract][Full Text] [Related]
10. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.
Kamijo T; Weber JD; Zambetti G; Zindy F; Roussel MF; Sherr CJ
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8292-7. PubMed ID: 9653180
[TBL] [Abstract][Full Text] [Related]
11. The INK4a/ARF tumor suppressor: one gene--two products--two pathways.
Chin L; Pomerantz J; DePinho RA
Trends Biochem Sci; 1998 Aug; 23(8):291-6. PubMed ID: 9757829
[TBL] [Abstract][Full Text] [Related]
12. Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex.
Weber JD; Kuo ML; Bothner B; DiGiammarino EL; Kriwacki RW; Roussel MF; Sherr CJ
Mol Cell Biol; 2000 Apr; 20(7):2517-28. PubMed ID: 10713175
[TBL] [Abstract][Full Text] [Related]
13. Multiple interacting domains contribute to p14ARF mediated inhibition of MDM2.
Clark PA; Llanos S; Peters G
Oncogene; 2002 Jul; 21(29):4498-507. PubMed ID: 12085228
[TBL] [Abstract][Full Text] [Related]
14. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G
Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594
[TBL] [Abstract][Full Text] [Related]
15. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
Honda R; Yasuda H
EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
[TBL] [Abstract][Full Text] [Related]
16. ARF function does not require p53 stabilization or Mdm2 relocalization.
Korgaonkar C; Zhao L; Modestou M; Quelle DE
Mol Cell Biol; 2002 Jan; 22(1):196-206. PubMed ID: 11739734
[TBL] [Abstract][Full Text] [Related]
17. MDM2-ARF complex regulates p53 sumoylation.
Chen L; Chen J
Oncogene; 2003 Aug; 22(34):5348-57. PubMed ID: 12917636
[TBL] [Abstract][Full Text] [Related]
18. CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus.
Hernández L; Beà S; Pinyol M; Ott G; Katzenberger T; Rosenwald A; Bosch F; López-Guillermo A; Delabie J; Colomer D; Montserrat E; Campo E
Cancer Res; 2005 Mar; 65(6):2199-206. PubMed ID: 15781632
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical inactivation of p14ARF concomitant with MDM2 overexpression inversely correlates with p53 overexpression in oral squamous cell carcinoma.
Sano T; Hikino T; Xue Q; Saito T; Kashiwabara K; Oyama T; Nakajima T
Pathol Int; 2000 Sep; 50(9):709-16. PubMed ID: 11012984
[TBL] [Abstract][Full Text] [Related]
20. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.
Pomerantz J; Schreiber-Agus N; Liégeois NJ; Silverman A; Alland L; Chin L; Potes J; Chen K; Orlow I; Lee HW; Cordon-Cardo C; DePinho RA
Cell; 1998 Mar; 92(6):713-23. PubMed ID: 9529248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
